AI-generated summary
The authors retrospectively reviewed 11 patients with Peutz-Jeghers syndrome treated for labial lentigines with a Q-switched Nd:YAG laser. After two to six sessions, eight patients had more than 75 percent lesion clearance and three had good responses. The authors report no recurrence in treated areas and no significant complications, and they conclude the laser is an effective and safe option.
- Participants
- 11
- Who or what was studied
- Patients diagnosed with Peutz-Jeghers syndrome who had labial lentigines
- Wavelengths
- 532 nm
- Limits stated in the abstract
- The study was retrospective with only 11 patients and no control group.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 532 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Light-emitting diode, Wavelength, Fluence, GRADE. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.